This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why MetLife (MET) is Worth Adding to Your Portfolio Now
by Zacks Equity Research
Business streamlining and a solid balance sheet poise MetLife for growth in 2019.
Zacks.com featured expert Kevin Matras highlights: Gulfport Energy, MetLife, Fiat Chrysler Automobiles, CVS Health and Barclays
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: Gulfport Energy, MetLife, Fiat Chrysler Automobiles, CVS Health and Barclays
5 Best GARP Picks with Discounted PEG
by Zacks Equity Research
To make a long-term investment more effective, the principles of both value and growth investing need to be combined.
Why Hold Strategy is Apt for Aon (AON) in Your Portfolio
by Zacks Equity Research
Backed by top-line growth, strategic endeavors and a solid cash trunk, Aon (AON) holds great potential to earn good returns for investors.
Zacks.com featured expert Kevin Matras highlights: Tech Data, ArcBest, MetLife, Gulfport Energy and Colfax
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: Tech Data, ArcBest, MetLife, Gulfport Energy and Colfax
Is MetLife (MET) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Is (MET) Outperforming Other Finance Stocks This Year?
6 Promising Price-to-Book Value Stocks to Buy Now
by Zacks Equity Research
P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high growth prospects.
Cigna (CI) & Units Receive Rating Actions From A.M. Best
by Zacks Equity Research
Credit rating giant A.M. Best affirms the ratings of Cigna (CI) and its subsidiaries.
Create a Value-Based Portfolio With These 5 Low P/CF Stocks
by Zacks Equity Research
One of the important factors that make P/CF a highly dependable metric is that operating cash flow adds back non-cash charges.
CME Group Gains 26% in a Year: Will the Rally Continue?
by Zacks Equity Research
Shares of CME Group (CME) rally 26.1% in a year, backed by solid fundamentals and initiatives to ramp up growth.
Why You Should Add Radian Group (RDN) to Your Portfolio
by Zacks Equity Research
Radian Group (RDN) rides on operational excellence and promises better rewards for investors.
Why You Should Add Brown & Brown (BRO) to Your Portfolio
by Zacks Equity Research
Brown & Brown (BRO) promises better reward for investors on operational excellence.
AIG's UK Unit Closes Buyout of Ellipse, Boosts Portfolio
by Zacks Equity Research
AIG's UK arm completes the pending purchase of Ellipse to strengthen its position in Life & Retirement businesses.
MGIC Investment New Business Written Growth Momentum Sustains
by Zacks Equity Research
Lower paid claims, solid new business written, better insurance in force and a firm capital position enable MGIC Investment (MTG) to emerge as a profitable pick for yield-seeking investors.
5 High Yielding S&P 500 Stocks to Buy for a Volatile 2019
by Nilanjan Choudhury
As we head into a period of high volatility in 2019, we have shortlisted five large-cap, dividend-paying companies to generate consistent cash distributions from the portfolio.
Should Value Investors Buy MetLife (MET) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks Value Trader Highlights: Citigroup, Huntsman, Macy???s, MetLife and Apple
by Zacks Equity Research
Zacks Value Trader Highlights: Citigroup, Huntsman, Macy???s, MetLife and Apple
Where to Find Stocks on Sale
by Tracey Ryniec
The largest stock market sell-off in 10 years has created a buying opportunity if you know where to look.
7 Low Price-to-Sales Stocks to Invest in for Solid Returns
by Zacks Equity Research
A stock with a price-to-sales below 1 is a good bargain, as investors need to pay less than a dollar for a dollar's worth.
Is AIG Doomed to Have a Terrible 2019 Too?
by Sapna Bagaria
A challenging property and casualty market, exposure to catastrophes, little gain on restructuring initiatives will keep the stock of AIG under pressure.
Top Ranked Value Stocks to Buy for December 26th
by Zacks Equity Research
Here are three stocks with buy rank and strong value characteristics for investors to consider today, December 26th:
Zacks.com featured highlights include: General Motors, MetLife, Echo Global, Barclays and CAI
by Zacks Equity Research
Zacks.com featured highlights include: General Motors, MetLife, Echo Global, Barclays and CAI
Cigna, Express Scripts Join Forces for Better Healthcare
by Zacks Equity Research
Cigna (CI) completes merger with Express Scripts. The new entity aims to provide affordable and flexible healthcare solutions to customers.
Add These 7 Low P/B Stocks to Your Portfolio for 2019
by Zacks Equity Research
P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high growth prospects.
Here's Why You Should Buy Willis Towers Watson Stocks Now
by Zacks Equity Research
Willis Towers Watson's (WLTW) organic growth, momentum in the exchange business and strong capital position make the stock apt to buy.